Strive (ASST) just posted third quarter 2026 results that put a spotlight on its complex mix of asset management, bitcoin holdings, and medical device operations after a sharp swing to reported profitability.
At a share price of $23.20, Strive has seen a 1 day share price return of 7.66% and a 7 day share price return of 12.68%, while the 30 day share price return is down 15.91% and the 1 year total shareholder return sits at 0.87%. This hints at strong short term momentum on the back of earnings and bitcoin related headlines after a much tougher three year total shareholder return decline of 31.16%.
Scan how Strive compares with other fast moving, higher risk plays using our curated list of 12 elite penny stocks with strong financials.
After a surge in reported earnings, a swelling Bitcoin treasury, and a sharp move in the share price, the real tension for Strive now sits in the numbers. Does the current valuation still compensate you for this level of risk?
Preferred Price-to-Book of 2.1x: Is It Justified For Strive?
Strive is being judged mostly on assets today rather than profits, because the group is still loss making with net income of a $294.002 million loss on $9.654 million of revenue. That is why the preferred yardstick here is the price-to-book ratio rather than an earnings based multiple.
The P/B multiple compares the market value of Strive to the accounting value of its net assets. For a company that remains unprofitable and runs a mix of asset management, a Bitcoin treasury approach, and medical devices, this metric gives you a simple check on what you are paying for that balance sheet versus peers.
On that score, the stock trades at 2.1x book value, which screens as good value against both the US Medical Equipment industry average P/B of 2.5x and a peer group average of 5.3x. The gap is wide, so the market is pricing Strive at a clear discount to similar businesses even though revenue grew by 75.1% over the past year and forecasts point to 5.7% annual top line growth, while the balance sheet is funded entirely by higher risk sources such as external borrowing rather than customer deposits.
Result: Price-to-book of 2.1x (UNDERVALUED).
See what the numbers say about this price — find out in our valuation breakdown.
Still, Strive carries clear pressure points, including a reported net loss of $294.002 million and reliance on a Bitcoin treasury strategy that can cause sharp swings in reported value.
Find out about the key risks to this Strive narrative.
Next Steps
Strive clearly splits opinion, with risks around losses and Bitcoin exposure set against potential rewards in assets and revenue. Act quickly to review the data, weigh both sides, and ground your own stance using the 1 key reward and 4 important warning signs.
Looking for more investment ideas beyond Strive?
If Strive has your attention, do not stop here. Fresh ideas often come from comparing it with other opportunities that match your risk and return preferences.
- Target potential mispricing opportunities by scanning companies that screen as 32 high quality undervalued stocks and see how their metrics stack up against Strive.
- Strengthen your focus on capital preservation by zeroing in on a list of solid balance sheet and fundamentals (23 results) that can better handle shocks.
- Hunt for under-the-radar potential by reviewing a curated set of 19 high quality undiscovered gems before the crowd pays attention.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com